¡Ya estamos en ! Descubre más
ABPWW

Abpro Holdings Warrant
ABPWW

Excluida de cotización

ABPWW dejó de cotizar en bolsa el 19 de febrero de 2026.

 

Acerca de: Abpro Holdings Inc is a biotechnology company dedicated to developing next-generation antibody therapeutics with the goal of improving the lives of patients with severe and life-threatening diseases. It is focused on novel antibody constructs for immuno-oncology and ophthalmology. By leveraging its proprietary DiversImmune and MultiMabTM antibody discovery and engineering platforms. The company is developing a pipeline of next-generation antibodies, both independently and through collaborations with pharmaceutical and research institutions.

Empleados: 6

Noticias

Positivo
Neutral
Negativo
Sentimiento 3 meses
Positivo 0%
Neutral 0%
Negativo 0%

No hemos recibido artículos de noticias recientes sobre ABPWW.

Gráficos de precios implementados con Lightweight Charts™